Efficacy of a Low Dose of Melatonin as an Adjunctive Therapy in Hospitalized Patients with COVID-19: A Randomized, Double-blind Clinical Trial

BACKGROUND: Melatonin has been known as an anti-inflammatory agent and immune modulator that may address progressive pathophysiology of coronavirus disease 2019 (COVID-19).Aim of the study. To evaluate the clinical efficacy of adjuvant, use of melatonin in patients with COVID-19. METHODS: This singl...

Descripción completa

Detalles Bibliográficos
Autores principales: Farnoosh, Gholamreza, Akbariqomi, Mostafa, Badri, Taleb, Bagheri, Mahdi, Izadi, Morteza, Saeedi-Boroujeni, Ali, Rezaie, Ehsan, Ghaleh, Hadi Esmaeili Gouvarchin, Aghamollaei, Hossein, Fasihi-ramandi, Mahdi, Hassanpour, Kazem, Alishiri, GholamHossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Instituto Mexicano del Seguro Social (IMSS). Published by Elsevier Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220995/
https://www.ncbi.nlm.nih.gov/pubmed/34229896
http://dx.doi.org/10.1016/j.arcmed.2021.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8220995/
https://www.ncbi.nlm.nih.gov/pubmed/34229896
http://dx.doi.org/10.1016/j.arcmed.2021.06.006

Ejemplares similares